1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Acyclovir |
| brand | String | Zovirax |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antivirals|Antiviral]] • [[:Category:Nucleoside_analogs|Nucleoside analog]] • [[:Category:Anti-herpesvirus_agents|Anti-herpesvirus agent]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000909-QINU`"', '"`UNIQ--vote-0000090A-QINU`"', '"`UNIQ--vote-0000090B-QINU`"', '"`UNIQ--vote-0000090C-QINU`"', '"`UNIQ--vote-0000090D-QINU`"', '"`UNIQ--vote-0000090E-QINU`"' |
| starting_dose | String | Initial genital herpes 400 mg PO TID × 7-10 days; episodic 800 mg TID × 2 days; suppression 400 mg BID; herpes zoster 800 mg 5×/day × 7 days; HSV encephalitis 10 mg/kg IV q8h × 14-21 days |
| preparations | String | 200, 400, 800 mg tablets; 200 mg capsules; 200 mg/5 mL suspension; 500, 1000 mg IV vials; 5% cream and ointment (topical) |
| fda_max | String | Indication-specific; high-dose IV regimens for encephalitis or disseminated disease |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV • topical |
| onset | String | Symptom relief within 24-48 hours of starting episodic treatment |
| duration | String | 8 hours per oral dose |
| halflife | String | ~3 hours; significantly prolonged in renal impairment'"`UNIQ--ref-0000090F-QINU`"' |
| bioavailability | String | ~20% (oral; valacyclovir prodrug raises this to ~55%)'"`UNIQ--ref-00000910-QINU`"' |
| pregnancy | String | Widely used in pregnancy for HSV/VZV indications; reassuring registry data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
